sixsense strategy group

As the year comes to a close, we want to take a moment to express our deepest gratitude to our incredible team and valued clients. To our amazing team: Your hard work, dedication, and unwavering commitment have been the driving force behind our success. Each of you contributes something special, and we are incredibly fortunate to have such a talented and passionate group of people. To our wonderful clients: Thank you for your continued support. We are grateful for the relationships we've built and the opportunities to grow together. We wish you all a festive and joyful holiday season filled with peace, happiness, and well-deserved relaxation. Here’s to a bright and successful 2025! #happyholidays #happyholidays2024 #merrychristmas #AskHerspiegel #growth #boitech #pharma

Patient centricity and cross-functional collaboration are the foundation of rare disease markets. Our proven strategies help ensure your product delivers value to both stakeholders and patients. Hear from our experts Dr. Kapil Raina, Brian Williams, and Chris Zealey: https://lnkd.in/eWi_rfB4 #MarketAccess #MedicalAffairs #LaunchExcellence #AskHerspiegel

Transform patient outcomes with support programs that deliver real results. From development to delivery, we help improve patient adherence, eliminate barriers, and demonstrate value. Read here: https://lnkd.in/eRgTxq_3 #PatientServices #AskHerspiegel

In the rare disease space, every launch decision counts. Transform complexity into a strategy to navigate expedited pathways, manage risk, and avoid launch delays. Hear from our experts Dr. Kapil Raina, Brian Williams, and Chris Zealey: https://lnkd.in/eYHYwDS5 #MarketAccess #MedicalAffairs #LaunchExcellence #AskHerspiegel

Launch archetypes are critical to navigating the complexities of rare disease markets. Read how patient-centric models help optimize product performance and successful market entry: https://lnkd.in/gGpuPHJ3 #LaunchExcellence #MarketingExcellence #RareDisease #AskHerspiegel

We're excited to welcome Zachary Zimmerman as a Senior Consultant on the Delivery team! Zach brings valuable experience in competitive intelligence consulting within the pharmaceutical sector, with expertise spanning general medicine, oncology, metabolism, and obesity. Join us in welcoming Zach to the team! #AskHerspiegel #LifeAtHerspiegel #Growth

We’re excited to welcome Andrew Toye Ojo, PhD as a Senior Science and Strategy Consultant to the Medical Affairs team! Toye is passionate about driving strategic business recommendations and advancing patient outcomes through data insights. Join us in welcoming Toye to the team! #lifeatherspiegel #AskHerspiegel #growth #SSG

We’re excited to welcome Sarah Skinner, PhD as a consultant to the Commercial Delivery team! Sarah brings valuable experience in life sciences consulting, with expertise in oncology, rare diseases, and competitive intelligence. Join us in welcoming Sarah to the team! #AskHerspiegel #lifeatHerspiegel #growth

We are excited to welcome Yvonne Kemps as a Senior Consultant on the Delivery team! With her extensive experience in the pharmaceutical and biotech sectors, Yvonne brings valuable expertise in innovations, growth strategies, regulatory approval, market access, and women’s health projects. Please join us in welcoming Yvonne to the team!

Dr. Kapil Raina, Brian Williams, and Chris Zealey share launch planning best practices for rare disease therapies, including budgeting, resource allocation, and stakeholder engagement strategies: https://lnkd.in/eSa2tdzX #AskHerspiegel #CommercialConversation #RareDisease #LaunchPlan